Skip to main content
logo
Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.7122
+0.0229 (3.32%)
At close: Aug 4, 2026, 4:00 PM EDT
0.7190
+0.0068 (0.95%)
After-hours: Aug 4, 2026, 4:16 PM EDT

Humacyte Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.022.04--1.571.26
Revenue Growth
----23.91%-15.29%
Gross Profit
-9.58-7.66--1.571.26
Operating Income
-113.89-108.14-114.4-100.05-84.58-81.21
Net Income
-75.32-40.83-148.7-110.78-10.4-25.21
Earnings Per Share
-0.57-0.26-1.26-1.07-0.12-0.66
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
48.5450.544.9480.45151.88225.5
Total Debt
65.964.8580.7857.4558.6451.18
Net Cash (Debt)
-17.36-14.35-35.842393.24174.32
Net Cash Growth
----75.34%-46.51%1923.02%
Net Cash Per Share
-0.10-0.09-0.300.220.904.36

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-101.55-105.04-98.12-73.31-71.13-81.19
Capital Expenditures
-0.83-0.88-1.57-2.28-1.05-0.22
Free Cash Flow
-102.38-105.93-99.69-75.59-72.18-81.41
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-475.05%-376.06%--100.00%100.00%
Operating Margin
-5649.21%-5306.04%---5404.35%-6429.77%
Pretax Margin
-3736.31%-2003.58%---664.54%-1996.36%
Profit Margin
-3736.31%-2003.58%---664.54%-1996.36%
FCF Margin
-5078.17%-5197.55%---4611.95%-6445.76%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
92.1990.96--139.18591.27